[1] WISPLINGHOFF H, BISCHOFF T, TALLENT S M, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study[J]. Clin Infect Dis, 2004, 39(3): 309-317. doi:  10.1086/421946
[2] World Health Organization. WHO fungal priority pathogens list to guide research, development and public health action [R]. Geneva, 2022. https://www.who.int/publications/i/item/9789240060241.
[3] PERLIN D S, RAUTEMAA-RICHARDSON R, ALASTRUEY-IZQUIERDO A. The global problem of antifungal resistance: prevalence, mechanisms, and management[J]. Lancet Infect Dis, 2017, 17(12): e383-e392. doi:  10.1016/S1473-3099(17)30316-X
[4] CLANCY C J, HONG NGUYEN M. Diagnosing invasive candidiasis[J]. J Clin Microbiol, 2018, 56(5): e01909-17.
[5] AL-GARAWI N A D, SUHAIL A, MERI M. Overview to candidiasis[J]. Med Sci J Adv Res, 2022, 3(1): 12-19. doi:  10.46966/msjar.v3i1.34
[6] REVIE N M, IYER K R, MAXSON M E, et al. Targeting fungal membrane homeostasis with imidazopyrazoindoles impairs azole resistance and biofilm formation[J]. Nat Commun, 2022, 13(1): 3634. doi:  10.1038/s41467-022-31308-1
[7] DAUM G, WAGNER A, CZABANY T, et al. Dynamics of neutral lipid storage and mobilization in yeast[J]. Biochimie, 2007, 89(2): 243-248. doi:  10.1016/j.biochi.2006.06.018
[8] LV Q Z, YAN L, JIANG Y Y. The synthesis, regulation, and functions of sterols in Candida albicans: Well-known but still lots to learn[J]. Virulence, 2016, 7(6): 649-659. doi:  10.1080/21505594.2016.1188236
[9] F. M. 奥斯伯, R. 布伦特, R. E. 金斯顿, 等. 精编分子生物学实验指南[M]. 北京: 科学出版社, 2008.
[10]

MARTEL C M, PARKER J E, BADER O, et al. Identification and characterization of four azole-resistant erg3 mutants of Candida albicans[J]. Antimicrob Agents Chemother, 2010, 54(11): 4527-4533. doi:  10.1128/AAC.00348-10
[11]

CHAU A S, GURNANI M, HAWKINSON R, et al. Inactivation of sterol Delta5, 6-desaturase attenuates virulence in Candida albicans[J]. Antimicrob Agents Chemother, 2005, 49(9): 3646-3651. doi:  10.1128/AAC.49.9.3646-3651.2005
[12]

LUNA-TAPIA A, WILLEMS H M E, PARKER J E, et al. Loss of Upc2p-inducible ERG3 transcription is sufficient to confer niche-specific azole resistance without compromising Candida albicans pathogenicity[J]. mBio, 2018, 9(3): e00225-18.
[13]

HIRAYAMA T, MIYAZAKI T, SUMIYOSHI M, et al. ERG3-encoding sterol C5, 6-DESATURASE in Candida albicans is required for virulence in an enterically infected invasive candidiasis mouse model[J]. Pathogens, 2020, 10(1): 23. doi:  10.3390/pathogens10010023